Lack of response of bone marrow, in vitro, to growth factors in congenital neutropenia.
AffiliationDepartment of Haematology, Christie Hospital, Manchester, United Kingdom.
MetadataShow full item record
AbstractSevere congenital neutropenia has a poor outlook. In vitro clonogenic assays using recombinant growth factors may improve understanding of the underlying pathogenetic mechanisms and identify those in whom growth factors might be clinically useful. Marrow from a boy with congenital neutropenia was cultured with a variety of recombinant growth factors. The results show that the neutropenia did not result from a lack of myeloid progenitors but that these progenitors could not produce mature neutrophils. Bone marrow transplantation is being considered as the most likely approach to correct neutropenia.
CitationLack of response of bone marrow, in vitro, to growth factors in congenital neutropenia. 1990, 35 (2):125-6 Am. J. Hematol.
JournalAmerican Journal of Hematology
- Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor.
- Authors: Vadhan-Raj S, Jeha SS, Buescher S, LeMaistre A, Yee G, Lu L, Lloreta J, Hoots WK, Hittelman WN, Gutterman JU
- Issue date: 1990 Feb 15
- Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
- Authors: Wright DG, LaRussa VF, Salvado AJ, Knight RD
- Issue date: 1989 Apr
- Severe congenital neutropenia: abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor.
- Authors: Hestdal K, Welte K, Lie SO, Keller JR, Ruscetti FW, Abrahamsen TG
- Issue date: 1993 Nov 15
- Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
- Authors: Haas R, Ogniben E, Kiesel S, Hohaus S, Baumann M, Körbling M, Dörken B, Hunstein W
- Issue date: 1989 Mar
- Interleukin-3 is significantly more effective than other colony-stimulating factors in long-term maintenance of human bone marrow-derived colony-forming cells in vitro.
- Authors: Kobayashi M, Van Leeuwen BH, Elsbury S, Martinson ME, Young IG, Hapel AJ
- Issue date: 1989 May 15